Literature DB >> 6420438

Progesterone modulation of pulsatile luteinizing hormone secretion in normal women.

M R Soules, R A Steiner, D K Clifton, N L Cohen, S Aksel, W J Bremner.   

Abstract

Recent studies show that the frequency and amplitude of pulsatile LH secretion change during the normal human menstrual cycle; however, the neuroendocrine mechanisms underlying these changes are poorly understood. To assess the role of progesterone (P) in regulating LH secretion patterns, we treated normal women (n = 5) with im P in oil during the follicular phase of their cycle and compared LH pulse frequency, amplitude, and mean plasma level during treatment to those in normal cycling women. Normal women were studied five times in five menstrual cycles. Each study lasted 24 h, with a sampling interval of 20 min. The cycle phases studied were early follicular (twice), late follicular (LF), midluteal, and LF with P therapy to simulate luteal phase plasma P levels. LH pulse frequency was slower (P less than or equal to 0.001) in the midluteal phase than in either the early follicular phase or LF, and furthermore, P, administered in the normal follicular phase, slowed LH pulse frequency, augmented pulse amplitude, and reduced mean plasma LH levels compared to those in untreated women studied at the same cycle phase (P less than or equal to 0.02). We infer that P secretion by the ovary mediates the change in the LH secretory pattern during the luteal phase of the normal menstrual cycle, and that at least part of this effect is mediated by the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6420438     DOI: 10.1210/jcem-58-2-378

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  49 in total

1.  Reproductive endocrine effects of acute exposure to toluene in men and women.

Authors:  U Luderer; M S Morgan; C A Brodkin; D A Kalman; E M Faustman
Journal:  Occup Environ Med       Date:  1999-10       Impact factor: 4.402

Review 2.  Exercise and secondary amenorrhoea linked through endogenous opioids.

Authors:  M T Ruffin; R E Hunter; E A Arendt
Journal:  Sports Med       Date:  1990-08       Impact factor: 11.136

3.  Glucocorticoids inhibit gonadotropin-releasing hormone by acting directly at the hypothalamic level.

Authors:  A E Calogero; N Burrello; A M Bosboom; M R Garofalo; R F Weber; R D'Agata
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

Review 4.  Endocrinology of the Menopause.

Authors:  Janet E Hall
Journal:  Endocrinol Metab Clin North Am       Date:  2015-09       Impact factor: 4.741

5.  Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls.

Authors:  Christopher R McCartney; Susan K Blank; Kathleen A Prendergast; Sandhya Chhabra; Christine A Eagleson; Kristin D Helm; Richard Yoo; R Jeffrey Chang; Carol M Foster; Sonia Caprio; John C Marshall
Journal:  J Clin Endocrinol Metab       Date:  2006-11-21       Impact factor: 5.958

Review 6.  The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.

Authors:  Mohamed F M Mitwally; Robert F Casper; Michael P Diamond
Journal:  Reprod Biol Endocrinol       Date:  2005-10-04       Impact factor: 5.211

7.  Biomathematical modeling of pulsatile hormone secretion: a historical perspective.

Authors:  William S Evans; Leon S Farhy; Michael L Johnson
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

8.  The Relationship Between Progesterone, Sleep, and LH and FSH Secretory Dynamics in Early Postmenarchal Girls.

Authors:  Bob Z Sun; Tairmae Kangarloo; Judith M Adams; Patrick Sluss; Donald W Chandler; David T Zava; John A McGrath; David M Umbach; Natalie D Shaw
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

9.  The negative feedback actions of progesterone on gonadotropin-releasing hormone secretion are transduced by the classical progesterone receptor.

Authors:  D C Skinner; N P Evans; B Delaleu; R L Goodman; P Bouchard; A Caraty
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

10.  Estradiol and progesterone-induced slowing of gonadotropin-releasing hormone pulse frequency is not reversed by subsequent administration of mifepristone.

Authors:  Christopher R McCartney; Susan K Blank; John C Marshall
Journal:  Endocrine       Date:  2009-07-16       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.